mycins')), C-19393 E59), asparenomycins10', pluracidomycins11), and SQ-27860'2', have been discovered from natural sources. On the basis of the stereochemistry of protons at the C-5,6 positions of the carbapenem nucleus, these carbapenem antibiotics, except the asparenomycins with a isopropylidene side chain at C-6 position, are grouped into cis compounds having a 5R,6R-configuration and trans compounds having a 5R,6S-configuration.
We reported that Streptomyres griseus suosp. cryophilus C-19393 produces eight 5,6-cis carbapenem antibiotics',', 13) and proposed a possible biosynthetic pathway for these 5,6-cis carbapenem antibiotics in this organisms". This paper deals with the antibacterial activities of the above twelve structurally related carbapenem antibiotics against 15 microorganisms and their structure-activity relations.
In addition, the contribution of amp C chromosomal 3-lactamase16), the permeability barriers? and penicillin-binding protein (PBP) lB18, 19) to the resistance of Escherichia coli to the carbapenem antibiotics will be presented.
Materials and Methods

Compounds
Eight natural 5,6-cis carbapenem antibiotics, i.e., epithienamycins A and B, C-19393 E5, C-19393 H2, MICs were determined by the two-fold agar dilution method as described previously20) Organisms Authentic cultures were obtained from the Institute for Fermentation, Osaka. Mutants derived from E. coli LD-2 (a lysine and 2,6-meso-diaminopimelic acid auxotroph'0'), which lacked 51-lactamase (amp C), the permeability barrier or PBP 1B21) , were used to examine the role of these cellular components in the antibiotic resistance of E. coli.
Results
Antibacterial Activities and Structure-activity Relations of 5,6-cis Carbapenem Antibiotics
The antibacterial activities of the 5,6-cis carbapenem antibiotics against 15 microorganisms are shown in Table 1 . For convenience, the antibiotics are grouped into four types according to the combination of the side chains at position C-8.
All the antibiotics, except MM 4550 and the three 8-dimethylsulfonyloxy compounds, showed superior antibacterial activities. The 8-monomethyl compounds were generally more potent than their corresponding 8-dimethyl ones. However, C-19393 H2 was far more potent than its corresponding monomethyl compound, C-19393 E5. On the other hand, the 8-hydroxyl compounds were more active than their corresponding 8-sulfonyloxy compounds. But, against two exceptional species, Klebsiella pneumoniae IFO 3317 and Pseudomonas aeruginosa IFO 3080, MM 17880 and MM 13902 were more active than their hydroxyl derivatives, epithienamycins A and B, respectively. The following structure-activity relations emerged using Staphylococcus aureus 209P and E. coli NIHJ JC-2 as a Gram-positive and a Gram-negative standard strain, respectively.
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Dehydrogenation of a Cysteamyl Side Chain at Position C-2 Table 2A shows the effect of this type of structural change on four combinations of carbapenem antibiotics. The dehydrogenation of the cysteamyl side chain hardly affected the antibacterial activity against either organism.
S-Oxidation in C-2 Side Chain
As shown in Table 2B , the effect on the activity of S-oxidation in the C-2 side chain greatly differed between 8-monomethyl and 8-dimethyl compounds; it greatly decreased the activities of the former, especially the sulfonyloxy-type, whereas it showed little effect on the activities of the latter. C-Methylation at Position C-8
C-Methylation at position C-8 of the 8-monomethyl compounds had a negative effect on activity except the change of C-19393 E5 to C-19393 H., and MM 4550 to C-19393 S, (Table 3A) . It is noteworthy that C-19393 H2 was much more active against E. coli NIHJ JC-2 than was C-19393 E5.
Sulfation at Position C-8
Generally, sulfation of 8-hydroxyl compounds resulting in 8-sulfonyloxy derivatives decreased the antibacterial activities (Table 3B ). This negative effect was remarkable with 8-dimethyl compounds.
The above conclusions apply to other microorganisms with two exceptions, Klebsiella pneumoniae IFO 3317 and Pseudoinonas aeruginosa IFO 3080. Comparison of the sensitivities to a given antibiotic between a mutant and its parent will clarify the contribution of the defective cellular component to the resistance of E. coli to the antibiotic. 
PBP 1B
It is well known that the lack of PBP 1B in E. coli results in supersensitivity to the (3-lactam antibiotics19,19,21) The data in column (C) of Table 4 shows that the PBP 1B-defective mutant (PG 8) is far more sensitive to the carbapenem antibiotics than its parent (CPC 20) as is the case with other types of (3-lactam antibiotics.
Discussion
The various types of structural change of the carbapenem antibiotics gave almost the same effects on activities against S. aureus and E. coli which represented a Gram-positive and a Gram-negative pathogenic bacterium, respectively. The following could be concluded from the results. (1) Dehydrogenation of the C-2 cysteamyl side chain did not affect antibacterial activities; (2) S-oxidation in the C-2 side chain decreased the activities of the 8-monomethyl compounds but not those of the 8-dimethyl compounds; (3) methylation at the C-8 position decreased the activities of compounds other than C-19393 E5 and MM 4550; and (4) sulfation at the C-8 position slightly decreased the activities of the 8-monomethyl compounds and greatly decreased those of the 8-dimethyl compounds. Observations on other bacteria confirmed these conclusions with few exceptions.
Beecham researchers have recently reported the effect of deacetylation of carbapenem antibiotics on antibacterial activities. NA 26978, a deacetylated derivative of epithienamycin A, showed much improved activity against P. aeruginosa and E. coli producing R-TEM 8-lactamase; that is, it had an antibacterial spectrum similar to that of thienamycin24).
Recently, OKONOGI et a1.25) reported that, of the 5,6-cis carbapenem antibiotics used in this study, the 8-dimethylsulfonyloxy compounds were the most active inhibitors of various types of (3-lactamases. However, we demonstrated that the 8-dimethylsulfonyloxy compounds showed the weakest antibacterial activity. The facts indicate that the binding affinities of the carbapenem antibiotics for target enzymes (PBPs) may greatly differ from those of the (3-lactamases.
The tolerance level of microorganisms toward /3-lactams is believed to be determined by (1) the amounts and specificities of (3-lactamases16.22,26) , (2) the diffusion rates of the 13-lactams through the permeability barrier17,23), and (3) the affinities of the (3-lactams for PBPs27).
The mode of action of carbapenem antibiotics, such as thienamycin28) and C-19393 S2 and H229, has been reported; the primary lethal effect is caused by prevention of the function of PBP 2 of E. coli, leading to the formation of ovoid cells. Thus, the affinities of several carbapenem antibiotics for the targets (PBPs) have been elucidated, but the contribution of a chromosomal 13-lactamase and the permeability barrier to the resistance to carbapenem antibiotics has not been reported.
E. coli produces a small amount of a chromosomal (3-lactamase coded for by amp C in the periplasmic space of cells. This enzyme activity is, however, so low that it does not contribute to the penicillin and cephalosporin tolerance level of this organism16, 22, 26) . In this study, we have demonstrated that the twelve 5,6-cis carbapenem antibiotics were equally active to the amp C (3-lactamase-negative mutant and its parent, indicating that this enzyme plays little or not part in the resistance of E. coli to the carbapenem antibiotics.
RICHMOND et al. 30 ) have developed an indirect, but very convenient, method for assessing the penetration of (3-lactams. It only involves measuring the MIC values against a permeability mutant of E. coli (DO 2 or DO 3) and its wild-type parent (UB 1005). The permeability of many penicillin and cephalosporin derivatives have been measured by the method", 81,32> In this study, we assayed the permeability of the carbapenem antibiotics by the same method using a similar type of permeability mutant (PG 12) and its parent (CPC 20) and demonstrated that these antibiotics easily permeate across the outer membrane of E. coli, which is believed to be a permeability barrier to various antibiotics.
TAMAKI et al. 13 ) and SuzUKI et al.") isolated PBP 1B-negative mutants of E. coli that are supersensitive to p-lactam antibiotics. The supersensitivity can be explained by the fact that PBP IA, a detour enzyme of PBP 113, shows a much higher affinity for p-lactam antibiotics than does PBP IB. As shown in column (C) of Table 4 , our PBP lB-negative mutant (PG 8)21> was also more sensitive to i3-lactam antibiotics, including the carbapenem antibiotics, than was its parental strain (CPC 20) . However, the ratios of the MIC values of the twelve carbapenem antibiotics against the mutant and the parent differed in the order of x 21 to x 21 probably because of the differences of their affinities for the residual essential PBPs (PBP IA, 2 and 3). By the use of this mutant as a detector strain for (3-lactam antibiotics in our screening program, we found novel (3-lactam antibiotics of natural origin"0, 33) Generally, the antibacterial activity of (3-lactam antibiotics against E. coli depends on binding affinities for the lethal targets (PBPs) located in the inner membrane, the permeability through the outer membrane, and the resistance to a N-lactamase located in the periplasm. We here demonstrated that the last two factors are negligible in explaining the activity of the 5,6-cis carbapenem antibiotics, and therefore, the antibacterial activity of these compounds seems to be reflect their affinities for essential PBPs in E. coli (PBP 1A, 1B, 2 and 3).
